Search results for "Reuptake"

showing 10 items of 96 documents

Antidepressant drugs and memory: Insights from animal studies

2007

This is a selective review of the literature concerning the effects of antidepressant drugs on animal memory, which was performed with the aid of the PubMed database. Monoamine oxidase inhibitors tend to either have no effect on memory or result in its improvement. Studies with cyclic antidepressants have reported no effect or, more often, memory impairments. Pre-training administration of selective serotonin reuptake inhibitors (SSRIs) has been shown to have either no effect on memory or undermine it (with some isolated exceptions, in which improvements have been recorded), while post-training administration of SSRIs has been demonstrated to improve memory or have no effect. A small group …

PharmacologyMonoamine Oxidase InhibitorsMonoamine oxidaseTrazodoneAntidepressive Agents TricyclicSerotonin reuptakePharmacologyAntidepressive AgentsRatsPsychiatry and Mental healthNeurologyMemorymedicineAnimalsConditioning OperantAntidepressantPharmacology (medical)Neurology (clinical)Animal studiesPsychologyNeuroscienceSelective Serotonin Reuptake InhibitorsBiological Psychiatrymedicine.drugEuropean Neuropsychopharmacology
researchProduct

Plasma levels and cerebrospinal fluid penetration by duloxetine in a patient with a non-fatal overdose during a suicide attempt

2009

Duloxetine is a potent and selective inhibitor of serotonin and norepinephrine reuptake with weak activity on dopamine reuptake (Wong et al. 1993). Daily doses of 60 mg are effective in the acute treatment of major depression. Duloxetine is extensively metabolized by cytochrome P450 isoenzymes (CYP) 1A2 and to a lesser extent 2D6 (Lobo et al. 2008) to numerous non-active metabolites. Maximum plasma concentration occurs after 6 h, steady-state within 3 d and the mean terminal half-life is 12 h. Fatal outcomes have been reported for acute overdoses as low as 1000 mg, and symptoms of duloxetine overdose are well described. However, information about plasma levels of duloxetine and correspondin…

Pharmacologybusiness.industryDuloxetine HydrochloridePharmacologyReuptakePsychiatry and Mental healthchemistry.chemical_compoundCerebrospinal fluidchemistryDopaminemedicineCerebrospinal fluid penetrationDuloxetinePharmacology (medical)SerotoninbusinessDepression (differential diagnoses)medicine.drugThe International Journal of Neuropsychopharmacology
researchProduct

Increased bioavailability of oral melatonin after fluvoxamine coadministration*1

2000

Background Fluvoxamine, a selective serotonin reuptake inhibitor, is known to elevate melatonin serum concentrations. It has not been clear whether these effects might be attributed to an increased melatonin production or to an decreased elimination of melatonin. The latter hypothesis was tested by this study. Methods Five healthy male volunteers (one CYP2D6 poor metabolizer) received 5 mg melatonin either with or without coadministration of 50 mg fluvoxamine. Serum concentrations of melatonin and fluvoxamine were assessed from 0 to 28 hours after melatonin intake. Results Coadministration of fluvoxamine, on average, led to an 17-fold higher (P <.05) area under concentration–time curve (AUC…

Pharmacologyendocrine systemmedicine.medical_specialtybusiness.industrySerotonin reuptake inhibitorCmaxFluvoxaminePharmacologyBioavailabilityMelatoninEndocrinologyPharmacokineticsOral administrationInternal medicinemedicinePharmacology (medical)Reuptake inhibitorbusinesshormones hormone substitutes and hormone antagonistsmedicine.drugClinical Pharmacology &amp; Therapeutics
researchProduct

Serotonin transporter gene polymorphism (5-HTTLPR) and emotional response to auditory hallucinations in schizophrenia

2005

The serotonin transporter (5-HTT) has a crucial function in the regulation of serotonin (5-HT) reuptake in presynaptic neurons. 5-HT is a major modulator of emotional behaviour and circadian rhythms. In addition to its neurotransmitter role, it is also an important regulator of morphogenetic activities during early brain development as well as during adult neurogenesis and plasticity (Murphy et al., 2001).

Pharmacologymedicine.medical_specialtybiologyNeurogenesismedicine.diseaseReuptakePsychiatry and Mental healthchemistry.chemical_compoundEndocrinologychemistrySchizophrenia5-HTTLPRInternal medicinemedicinebiology.proteinPharmacology (medical)SerotoninCircadian rhythmNeurotransmitterNeuroscienceSerotonin transporterThe International Journal of Neuropsychopharmacology
researchProduct

A novel arousal-based individual screening reveals susceptibility and resilience to PTSD-like phenotypes in mice

2021

Translational animal models for studying post-traumatic stress disorder (PTSD) are valuable for elucidating the poorly understood neurobiology of this neuropsychiatric disorder. These models should encompass crucial features, including persistence of PTSD-like phenotypes triggered after exposure to a single traumatic event, trauma susceptibility/resilience and predictive validity. Here we propose a novel arousal-based individual screening (AIS) model that recapitulates all these features. The AIS model was designed by coupling the traumatization (24 h restraint) of C57BL/6 J mice with a novel individual screening. This screening consists of z-normalization of post-trauma changes in startle …

Physiology5-trial SM 5-trial social memoryBiochemistryFight-or-flight responseFST forced swim test0302 clinical medicineEndocrinologySSRIs selective serotonin reuptake inhibitorsDSM-5 Diagnostic and Statistical Manual of Mental DisordersOriginal Research ArticleFear conditioningmedia_commonHT hypothalamusAIS arousal-based individual screeningQP351-495ParoxetinePhenotypeHPA hypothalamic–pituitary–adrenalBST basal synaptic transmissionHIP hippocampusPTSD post-traumatic stress disorder[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]Psychological resilienceAmy amygdalaRC321-571medicine.drugNeurophysiology and neuropsychologymedia_common.quotation_subjectBDNF brain derived neurotropic factorFear conditioningNeurosciences. Biological psychiatry. NeuropsychiatryBiologyStressArousal03 medical and health sciencesCellular and Molecular NeuroscienceAnimal model Fear conditioning Resilience Stress Susceptibility Z-scoreAnimal modelCORT corticosteroneOF open fieldTE trauma-exposedBiological neural networkmedicineAnimal model[SDV.NEU] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]C controlfEPSPs field excitatory post-synaptic potentialsSGK1 serum/glucocorticoid-regulated kinase 1RC346-429Molecular BiologyResilienceEndocrine and Autonomic SystemsZ-scoremPFC medial prefrontal cortexFKBP5 FK506 binding protein 5FDA Food and Drug AdministrationASR acoustic startle reactivityEPM elevated plus maze030227 psychiatrySusceptibilityAnimal model; Fear conditioning; Resilience; Stress; Susceptibility; Z-scoreNeurology. Diseases of the nervous systemNeuroscience030217 neurology & neurosurgeryNeurobiology of Stress
researchProduct

Serotonin dysfunction syndromes: a functional common denominator for classification of depression, anxiety, and obsessive-compulsive disorder.

1993

Psychiatric Status Rating Scalesmedicine.medical_specialtyDepressive DisorderObsessive-Compulsive DisorderSerotoninCommon denominatormedicine.diseaseAnxiety DisordersSerotonin Receptor AgonistsPsychiatry and Mental healthObsessive compulsiveReceptors SerotoninPsychiatric status rating scalesmedicineAnxietyHumansPharmacology (medical)SerotoninSerotonin Antagonistsmedicine.symptomPsychiatryPsychologyAnxiety disorderDepression (differential diagnoses)Selective Serotonin Reuptake InhibitorsInternational clinical psychopharmacology
researchProduct

Development of predictive retention-activity relationship models of tricyclic antidepressants by micellar liquid chromatography.

1999

The distribution of tricyclic antidepressants from plasma to brain, where these drugs exert their main clinical action, and other organs is related to transport events across the cell membranes of the different tissues. It could be expected that all the molecular features that condition the transport processes (mainly hydrophobicity and molar total charge) also control the pharmacokinetic and biochemical behavior. Micellar liquid chromatography (MLC) has been proposed to emulate in vitro the partitioning process in the biomembranes. The use of micellar solutions of Brij35 as mobile phases in reversed-phase liquid chromatography has proven to be valid to predict the biological activities of …

SerotoninAntidepressive Agents TricyclicModels BiologicalMicellar electrokinetic chromatographyNorepinephrineStructure-Activity RelationshipPharmacokineticsReceptors Adrenergic alpha-1Drug DiscoveryDistribution (pharmacology)AnimalsEnzyme InhibitorsAdrenergic alpha-AntagonistsMicelleschemistry.chemical_classificationChromatographyChemistryCapacity factorRatsMembraneMicellar liquid chromatographyMicellar solutionsAdenylyl Cyclase InhibitorsHistamine H1 AntagonistsMolecular MedicineSelective Serotonin Reuptake InhibitorsTricyclicChromatography LiquidJournal of medicinal chemistry
researchProduct

Differential Effects of Fluvoxamine and Other Antidepressants on the Biotransformation of Melatonin

2001

Melatonin, the predominant product of the pineal gland, is involved in the maintenance of diurnal rhythms. Nocturnal blood concentrations of melatonin have been shown to be enhanced by fluvoxamine, but not by other serotonin reuptake inhibitors. Because fluvoxamine is an inhibitor of several cytochrome P450 (CYP) enzymes, the authors studied the biotransformation of melatonin and the effects of fluvoxamine on the metabolism of melatonin in vitro using human liver microsomes and recombinant human CYP isoenzymes. Melatonin was found to be almost exclusively metabolized by CYP1A2 to 6-hydroxymelatonin and N-acetylserotonin with a minimal contribution of CYP2C19. Both reactions were potently in…

Serotoninendocrine systemmedicine.medical_specialty10050 Institute of Pharmacology and Toxicology610 Medicine & healthFluvoxamineCitalopramPharmacologyImipramineMelatonin2738 Psychiatry and Mental HealthPineal glandTheophyllineCytochrome P-450 CYP1A2Internal medicineDesipraminemedicineHumans2736 Pharmacology (medical)Pharmacology (medical)Enzyme InhibitorsMelatoninFluoxetineChemistryPsychiatry and Mental healthmedicine.anatomical_structureEndocrinologyFluvoxamineMicrosomes LiverAntidepressive Agents Second-Generation570 Life sciences; biologyReuptake inhibitorhormones hormone substitutes and hormone antagonistsmedicine.drugJournal of Clinical Psychopharmacology
researchProduct

Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor

2003

Antidepressants are commonly supposed to enhance serotonergic and/or noradrenergic neurotransmission by inhibition of neurotransmitter reuptake through binding to the respective neurotransmitter transporters or through inhibition of the monoamine oxidase. Using the concentration-clamp technique and measurements of intracellular Ca2+, we demonstrate that different classes of antidepressants act as functional antagonists at the human 5-HT3A receptor stably expressed in HEK 293 cells and at endogenous 5-HT3 receptors of rat hippocampal neurons and N1E-115 neuroblastoma cells. The tricyclic antidepressants desipramine, imipramine, and trimipramine, the serotonin reuptake inhibitor fluoxetine, t…

Serotoninmedicine.medical_specialtySerotonin reuptake inhibitorMirtazapinePharmacologyKidneySerotonergicHippocampusNoradrenergic and specific serotonergic antidepressantCell LineMembrane PotentialsReuptakeNeuroblastomaCellular and Molecular NeuroscienceNorepinephrine reuptake inhibitorCell Line TumorInternal medicineDesipraminemedicineAnimalsHumansSerotonin 5-HT3 Receptor AntagonistsPharmacology (medical)Molecular BiologyNeuronsChemistryGeneral MedicineTrimipramineAntidepressive AgentsRatsPsychiatry and Mental healthEndocrinology5-HT6 receptorCalciumReceptors Serotonin 5-HT3medicine.drugPharmacopsychiatry
researchProduct

Diagnostic techniques and multidisciplinary approach in idiopathic granulomatous mastitis: A revision of the literature

2019

Idiopathic granulomatous mastitis (IGM) is a chronic benign inflammatory disease of the breast that may mimic breast cancer. It is most common in parous young fertile women, although it can occur in nulliparous women and in men. IGM is an idiopathic disease due to the influence of some environmental factors in genetically predisposed subjects. Several pathogenic hypothesis have been proposed in the last years (autoimmune, hormonal, infective genesis). IGM presents as a painful palpable mass located in one of the two udders. The skin is usually normal but could present signs of inflammation with or without lymph nodes involvement. Ultrasonography, mammography, magnetic resonance can be diagn…

Settore MED/18 - Chirurgia GeneraleBreast cancerIdiopatic mastitiHumansidiopatic mastitisFemaleReviewGranulomatous MastitisChronic benign inflammatory diseaseSelective Serotonin Reuptake Inhibitors
researchProduct